Psychiatric Solutions, Inc.
Psychiatric Solutions reports 181% fourth quarter revenue increase
Published in Healthcare Mergers, Acquisitions and Ventures Week, April 10th, 2004
Revenue for the fourth quarter grew 181% to $100,653,000 from $35,838,000 for the fourth quarter of 2002.
Net income available to common stockholders for the fourth quarter was $2,284,000 compared with $2,466,000 for the fourth quarter of 2002, while earnings per diluted share were $0.19 for the latest quarter compared with $0.30 for the fourth quarter of 2002.
PSI's income tax rate was 38% for the fourth quarter of 2003, in contrast to the $1,028,000 tax benefit the company received for the fourth quarter of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- AVI BioPharma, Inc.
Neugene maker reports quarterly loss of $0.10 per share - Alfacell Corporation
Savadelis named chief financial officer at pharmaceutical firm - Allos Therapeutics, Inc.
Oncology company files shelf registration statement - Alnylam Pharmaceuticals, Inc.
Isis Pharmaceuticals enters RNAi alliance - American Oriental Bioengineering
Bioengineering firm expects record revenue growth, income for 2003 - Aspreva Pharmaceuticals Corp.
Autoimmune disease drug maker completes raises $57 million - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
